Recording Weight Advisable at All Ages in General Medicine Recording Weight Advisable at All Ages in General Medicine
In general practice, recording a patient ' s weight helps detect those at risk of metabolic syndrome, but this task is not performed routinely for men or patients with no comorbidities.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 8, 2022 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

New Eosinophilic Esophagitis Severity Score May Guide Treatment New Eosinophilic Esophagitis Severity Score May Guide Treatment
The index, called I-SEE, includes symptoms, endoscopic findings, and histology and is meant to help steer clinicians to the best treatment strategy.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 8, 2022 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news

Therapies for Managing Cirrhosis and its Complications Therapies for Managing Cirrhosis and its Complications
This review outlines the currently available and emerging therapeutic options for the treatment of cirrhosis and its complications.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 8, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

First-Line Anti-EGFR Extends OS in Left-Sided Colorectal Cancer
(MedPage Today) -- CHICAGO -- In carefully selected patients diagnosed with metastatic colorectal cancer receiving standard first-line chemotherapy, treatment with the EGFR inhibitor panitumumab (Vectibix) significantly extended survival compared... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 8, 2022 Category: Gastroenterology Source Type: news

Bidirectional Risk Seen for Inflammatory Bowel Disease, Depression
TUESDAY, June 7, 2022 -- There is a bidirectional association between inflammatory bowel disease (IBD) and depression, according to a study recently published in the Journal of Gastroenterology and Hepatology. Bing Zhang, M.D., from the Keck School... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2022 Category: Pharmaceuticals Source Type: news

Artificial Intelligence Colonoscopy System Shows Promise Artificial Intelligence Colonoscopy System Shows Promise
A new artificial intelligence colonoscopy system improved the accuracy of experienced endoscopists in the United States.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 7, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

CRC Risk Lower When Patients' Docs Are Better at Adenoma Detection
(MedPage Today) -- Risk for colorectal cancer (CRC) following a colonoscopy was lower when the colonoscopy was conducted by a physician with higher adenoma detection rates (ADRs), a retrospective study of three large health systems found. Every... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 7, 2022 Category: Gastroenterology Source Type: news

Iatrogenic Tumor Seeding via Colonoscopy Unlikely Iatrogenic Tumor Seeding via Colonoscopy Unlikely
Biopsy of noncancerous sites after biopsy of a colorectal cancer confers no meaningfully higher risk of metachronous cancer, despite biologic plausibility.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Updated Guideline Prompts Younger People to Undergo CRC Screening Updated Guideline Prompts Younger People to Undergo CRC Screening
A new study shows that Americans are getting their first colonoscopies at 45 years old following the update to the US colorectal cancer screening guidelines.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 6, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Liquid Biopsy May Save Colon Cancer Patients From Chemo
(MedPage Today) -- CHICAGO – Early colon cancer patients who have circulating tumor DNA detected in blood may need more aggressive treatment, but people who have a negative liquid biopsy appear to be safe in avoiding chemotherapy –... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 6, 2022 Category: Gastroenterology Source Type: news

ASCO: ctDNA Analysis  Guides Treatment of Stage II Colon Cancer
ctDNA - guided approach to determining the need for adjuvant therapy noninferior to standard management for recurrence - free survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 6, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Pharmacy, Conference News, Source Type: news

Radiation Segmentectomy Efficacious for Unresectable Liver Cancer
All patients had initial objective response and 90 percent had sustained complete response; few patients had high - grade adverse events (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 6, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Radiology, Surgery, Journal, Source Type: news

Study Uncovers Strong Links Between Depression and Crohn ’ s, Colitis
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 6, 2022 Category: Psychiatry Tags: Gastroenterology, Psychiatry, Rheumatology, News, Source Type: news

Crohn's Disease Biomarker Appears Years Ahead of Diagnosis Crohn's Disease Biomarker Appears Years Ahead of Diagnosis
Sign of immune disruption could complement other prodromal signs of early or aggressive Crohn ' s disease and point the way to new therapies.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 6, 2022 Category: Primary Care Tags: Gastroenterology News Source Type: news

Risankizumab Eases Moderate to Severe Crohn's Disease
(MedPage Today) -- Risankizumab (Skyrizi) was safe and effective for patients with moderate to severe Crohn's disease (CD), according to two phase III induction trials and a maintenance trial. All co-primary endpoints were met at week 12 for the... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 6, 2022 Category: Gastroenterology Source Type: news